|
1
|
Mayer BJ, Hamaguchi M and Hanafusa H: A
novel viral oncogene with structural similarity to phospholipase C.
Nature. 332:272–275. 1988.
|
|
2
|
Kanner SB, Reynolds AB and Parsons JT:
Tyrosine phosphorylation of a 120-kilodalton pp60src substrate upon
epidermal growth factor and platelet-derived growth factor receptor
stimulation and in polyomavirus middle-T-antigen-transformed cells.
Mol Cell Biol. 11:713–720. 1991.
|
|
3
|
Deng B, Huang W, Tan QY, et al: Breast
cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in
pulmonary disease tissue and serum. Mol Diagn Ther. 15:31–40.
2011.
|
|
4
|
Huang W, Deng B, Wang RW, et al: BCAR1
protein plays important roles in carcinogenesis and predicts poor
prognosis in non-small-cell lung cancer. PLoS One.
7:e361242012.
|
|
5
|
Wendt MK, Smith JA and Schiemann WP:
p130Cas is required for mammary tumor growth and transforming
growth factor-beta-mediated metastasis through regulation of
Smad2/3 activity. J Biol Chem. 284:34145–34156. 2009.
|
|
6
|
Bakin AV, Rinehart C, Tomlinson AK and
Arteaga CL: p38 mitogen-activated protein kinase is required for
TGFbeta-mediated fibroblastic transdifferentiation and cell
migration. J Cell Sci. 115:3193–3206. 2002.
|
|
7
|
Kolosova I, Nethery D and Kern JA: Role of
Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal
transition of pulmonary epithelial cells. J Cell Physiol.
226:1248–1254. 2011.
|
|
8
|
Galliher AJ, Neil JR and Schiemann WP:
Role of transforming growth factor-beta in cancer progression.
Future Oncol. 2:743–763. 2006.
|
|
9
|
del Barco Barrantes I and Nebreda AR:
Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans.
40:79–84. 2012.
|
|
10
|
Yang J, Song K, Krebs TL, Jackson MW and
Danielpour D: Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced
apoptosis and tumor progression. Oncogene. 27:5326–5338. 2008.
|
|
11
|
Yang J, Wahdan-Alaswad R and Danielpour D:
Critical role of Smad2 in tumor suppression and transforming growth
factor-beta-induced apoptosis of prostate epithelial cells. Cancer
Res. 69:2185–2190. 2009.
|
|
12
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009.
|
|
13
|
Nelson CM, Khauv D, Bissell MJ and Radisky
DC: Change in cell shape is required for matrix
metalloproteinase-induced epithelial-mesenchymal transition of
mammary epithelial cells. J Cell Biochem. 105:25–33. 2008.
|
|
14
|
Hayashida T, Jinno H, Kitagawa Y and
Kitajima M: Cooperation of cancer stem cell properties and
epithelial-mesenchymal transition in the establishment of breast
cancer metastasis. J Oncol. 2011:5914272011.
|
|
15
|
Lo JF, Yu CC, Chiou SH, et al: The
epithelial-mesenchymal transition mediator S100A4 maintains
cancer-initiating cells in head and neck cancers. Cancer Res.
71:1912–1923. 2011.
|
|
16
|
Maitah MY, Ali S, Ahmad A, Gadgeel S and
Sarkar FH: Up-regulation of sonic hedgehog contributes to
TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells.
PLoS One. 6:e160682011.
|
|
17
|
Joshi A and Cao D: TGF-beta signaling,
tumor microenvironment and tumor progression: the butterfly effect.
Front Biosci (Landmark Ed). 15:180–194. 2010.
|
|
18
|
Yang L, Pang Y and Moses HL: TGF-beta and
immune cells: an important regulatory axis in the tumor
microenvironment and progression. Trends Immunol. 31:220–227.
2010.
|
|
19
|
Taylor MA, Lee YH and Schiemann WP: Role
of TGF-β and the tumor microenvironment during mammary
tumorigenesis. Gene Expr. 15:117–132. 2011.
|
|
20
|
Iwata J, Hacia JG, Suzuki A, Sanchez-Lara
PA, Urata M and Chai Y: Modulation of noncanonical TGF-β signaling
prevents cleft palate in Tgfbr2 mutant mice. J Clin Invest.
122:873–885. 2012.
|
|
21
|
Greenberg AK, Basu S, Hu J, et al:
Selective p38 activation in human non-small cell lung cancer. Am J
Respir Cell Mol Biol. 26:558–564. 2002.
|
|
22
|
Pirozzi G, Tirino V, Camerlingo R, et al:
Epithelial to mesenchymal transition by TGFβ-1 induction increases
stemness characteristics in primary non small cell lung cancer cell
line. PLoS One. 6:e215482011.
|
|
23
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005.
|
|
24
|
Araki K, Shimura T, Suzuki H, et al:
E/N-cadherin switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011.
|
|
25
|
Miao Y, Li AL, Wang L, et al: Expression
of p130cas, E-cadherin and β-catenin and their correlation with
clinicopathological parameters in non-small cell lung cancer:
p130cas over-expression predicts poor prognosis. Folia Histochem
Cytobiol. 50:392–397. 2012.
|
|
26
|
Tikhmyanova N and Golemis EA: NEDD9 and
BCAR1 negatively regulate E-cadherin membrane localization, and
promote E-cadherin degradation. PLoS One. 6:e221022011.
|
|
27
|
Hong J, Zhou J, Fu J, et al:
Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1
protein and promotes breast cancer cell invasiveness. Cancer Res.
71:3980–3990. 2011.
|
|
28
|
Hipp S, Berg D, Ergin B, et al:
Interaction of Snail and p38 mitogen-activated protein kinase
results in shorter overall survival of ovarian cancer patients.
Virchows Arch. 457:705–713. 2010.
|
|
29
|
Ramos C, Becerril C, Montaño M, et al:
FGF-1 reverts epithelial-mesenchymal transition induced by
TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell
Mol Physiol. 299:L222–L231. 2010.
|
|
30
|
Miles FL, Tung NS, Aguiar AA, Kurtoglu S
and Sikes RA: Increased TGF-β1-mediated suppression of growth and
motility in castrate-resistant prostate cancer cells is consistent
with Smad2/3 signaling. Prostate. 72:1339–1350. 2012.
|
|
31
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-beta1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:562005.
|
|
32
|
Liu LC, Tsao TC, Hsu SR, et al: EGCG
inhibits transforming growth factor-β-mediated
epithelial-to-mesenchymal transition via the inhibition of Smad2
and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. J
Agric Food Chem. 60:9863–9873. 2012.
|
|
33
|
Filyak Y, Filyak O, Souchelnytskyi S and
Stoika R: Doxorubicin inhibits TGF-beta signaling in human lung
carcinoma A549 cells. Eur J Pharmacol. 590:67–73. 2008.
|
|
34
|
Yanagisawa K, Uchida K, Nagatake M, et al:
Heterogeneities in the biological and biochemical functions of
Smad2 and Smad4 mutants naturally occurring in human lung cancers.
Oncogene. 19:2305–2311. 2000.
|
|
35
|
Lagadec C, Meignan S, Adriaenssens E, et
al: TrkA overexpression enhances growth and metastasis of breast
cancer cells. Oncogene. 28:1960–1970. 2009.
|
|
36
|
Zhang Y, Rivera Rosado LA, Moon SY and
Zhang B: Silencing of D4-GDI inhibits growth and invasive behavior
in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK
signaling. J Biol Chem. 284:12956–12965. 2009.
|
|
37
|
Owens TW, Valentijn AJ, Upton JP, et al:
Apoptosis commitment and activation of mitochondrial Bax during
anoikis is regulated by p38MAPK. Cell Death Differ. 16:1551–1562.
2009.
|
